The antiarrhythmic properties of BL-3677A.
D000772:Anesthesia, Local; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy* / Q000517:prevention & control; D001794:Blood Pressure / Q000187:drug effects; D001643:Bridged Bicyclo Compounds; D001952:Bridged-Ring Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D003331:Coronary Vessels / Q000502:physiology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D006321:Heart / Q000187:drug effects; D006329:Heart Conduction System / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D007094:Imides / Q000627:therapeutic use*; D007441:Intubation, Gastrointestinal; D054833:Isoindoles; D007545:Isoproterenol / Q000494:pharmacology; D008012:Lidocaine / Q000627:therapeutic use; D008026:Ligation; D010042:Ouabain; D011342:Procainamide / Q000627:therapeutic use; D011437:Propylamines / Q000627:therapeutic use; D013610:Tachycardia / Q000139:chemically induced; D013997:Time Factors
D000889:Anti-Arrhythmia Agents; D001643:Bridged Bicyclo Compounds; D001952:Bridged-Ring Compounds; D007094:Imides; D054833:Isoindoles; D011437:Propylamines; D010042:Ouabain; D008012:Lidocaine; D011342:Procainamide; D007545:Isoproterenol; C006178:BL 3677A